Net Profit Growth of Joincare in 2014, Health Care Product Performance Lowered by Unfavorable Traditional Channel
 
    On the night of Mar. 30, Joincare(600380) issues its annual report of 2014. The company registered a business income of RMB7.418 billion, up 19.26% year on year, with net profit of RMB354 million, increasing 29.46% than the previous year, and RMB0.2292 earnings for each share. The company proposes to distribute RMB1(tax included) for every 10 shares of all shareholders, based on the general equity of the company on the date of record as confirmed in the Profit Distribution Scheme in 2014. Major products of the company include the research, development, production and operation of TCM, health care products and west medicines. In 2014, health care income of the company reached RMB274 million, down 9% compared to the same period of the previous year, and accounting for 3.69% of the company’s total income, down 1.2%. The decline in health care products is primarily resulted from the consumers’ transfer from the original gift market to the current self-use and Internet purchase way. The growth of business of the company comes from the increase in the sales of preparations and bulk drugs. As to the health care products during the report period, while maintaining the existing promotion and pushing into the county and town level markets, the company’s health care products will continue to enhance and deepen the marketing system reform, and have support for product integration and new product development through constructive proposal, analysis, positioning and evaluation on the health care products and OTC products by external renowned consultation companies.